Consolidated Statement of Changes in Equity

Note (20)	Interests of shareholders of BRAIN Biotech AG					Non-controlling interests
€ thousand	Subscribed capital	Capital reserves	Retained earnings	Other reserves Currency translation	Total	Total	Total
Balance as at 30 September 2021/1 October 2022	21,847	92,660	-85,198	328	29,638	4,610	34,248
Net result for the reporting period	0	0	-8,279	0	-8,279	165	-8,114
Other comprehensive income	0	0	25	299	324	-9	315
Total comprehensive income (loss)	0	0	-8,255	299	-7,956	156	-7,799
Exercise of put/call agreements for the acquisition of non-controlling interests in fully consolidated Group companies	0	0	1,795	0	1,795	-1,795	0
Acquisition of shares of non-controlling shareholders	0	0	-2,504	0	-2,504	-1,728	-4,232
Transfers due to employee share scheme	0	797	0	0	797	0	797
Balance as at 30 September 2022/1 October 2023	21,847	93,457	-94,161	627	21,770	1,243	23,013
Net result for the reporting period	0	0	-11,127	0	-11,127	27	-11,100
Other comprehensive income	0	0	-207	686	479	0	479
Total comprehensive income (loss)	0	0	-11,334	686	-10,648	27	-10,621
Allocation to capital reserves from convertible bond issue less issuance costs	0	600	0	0	600	0	600
Transfers due to employee share scheme	0	894	0	0	894	0	894
Balance as at 30 September 2024	21,847	94,951	-105,494	1,313	12,617	1,269	13,886